A service of StreetInsider.com
Ticker Symbol

Most Popular

AAPL 118.55
GOOG 538.80
MSFT 47.90
BAC 17.06
FB 77.30

Recently Added

EVC 6.28
SPG 180.38
R 93.92
SKX 60.35
CTRE 15.89

Gaining Speed

EVC 6.28
TMO 128.13
BABA 112.75
SPN 23.56
FB 77.30

ZIOPHARM Oncology (ZIOP) Reports Palifosfamide Hits PFS Events in Phase 3

ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) announced today that the Phase 3 (PICASSO 3) trial of palifosfamide (ZIO-201) in first-line metastatic soft tissue sarcoma has reached its target number of progression-free survival (PFS) events. PICASSO 3 is an international, randomized, double-blind, placebo-controlled trial whose primary endpoint is PFS....

Read More

Get Alerted When News Hits On This Stock - FREE!